» Articles » PMID: 27015521

Complications and Safety of Vagus Nerve Stimulation: 25 Years of Experience at a Single Center

Overview
Specialties Neurosurgery
Pediatrics
Date 2016 Mar 26
PMID 27015521
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

OBJECTIVE The goal of this paper was to investigate surgical and hardware complications in a longitudinal retrospective study. METHODS The authors of this registry study analyzed the surgical and hardware complications in 247 patients who underwent the implantation of a vagus nerve stimulation (VNS) device between 1990 and 2014. The mean follow-up time was 12 years. RESULTS In total, 497 procedures were performed for 247 primary VNS implantations. Complications related to surgery occurred in 8.6% of all implantation procedures that were performed. The respective rate for hardware complications was 3.7%. Surgical complications included postoperative hematoma in 1.9%, infection in 2.6%, vocal cord palsy in 1.4%, lower facial weakness in 0.2%, pain and sensory-related complications in 1.4%, aseptic reaction in 0.2%, cable discomfort in 0.2%, surgical cable break in 0.2%, oversized stimulator pocket in 0.2%, and battery displacement in 0.2% of patients. Hardware-related complications included lead fracture/malfunction in 3.0%, spontaneous VNS turn-on in 0.2%, and lead disconnection in 0.2% of patients. CONCLUSIONS VNS implantation is a relatively safe procedure, but it still involves certain risks. The most common complications are postoperative hematoma, infection, and vocal cord palsy. Although their occurrence rates are rather low at about 2%, these complications may cause major suffering and even be life threatening. To reduce complications, it is important to have a long-term perspective. The 25 years of follow-up of this study is of great strength considering that VNS can be a life-long treatment for many patients. Thus, it is important to include repeated surgeries such as battery and lead replacements, given that complications also may occur with these surgeries.

Citing Articles

A pooled analysis of the side effects of non-invasive Transcutaneous Auricular Vagus Nerve Stimulation (taVNS).

Giraudier M, Ventura-Bort C, Szeska C, Weymar M Front Hum Neurosci. 2025; 19:1539416.

PMID: 39981126 PMC: 11841445. DOI: 10.3389/fnhum.2025.1539416.


Vagal nerve stimulation for the management of long COVID symptoms.

Khan M, Ahmad M, Qudrat S, Afridi F, Khan N, Afridi Z Infect Med (Beijing). 2024; 3(4):100149.

PMID: 39678231 PMC: 11638592. DOI: 10.1016/j.imj.2024.100149.


Safety and feasibility of paired vagus nerve stimulation with rehabilitation for improving upper extremity function in people with cervical spinal cord injury: study protocol for a pilot randomized controlled trial.

Yozbatiran N, Francisco G, Korupolu R Front Neurol. 2024; 15:1465764.

PMID: 39610700 PMC: 11604078. DOI: 10.3389/fneur.2024.1465764.


Vagus nerve stimulation: Novel concept for the treatment of glioblastoma and solid cancers by cytokine (interleukin-6) reduction, attenuating the SASP, enhancing tumor immunity.

Brem S Brain Behav Immun Health. 2024; 42:100859.

PMID: 39512605 PMC: 11541944. DOI: 10.1016/j.bbih.2024.100859.


Effects of online and offline trigeminal nerve stimulation on visuomotor learning.

Arias D, Buneo C Front Hum Neurosci. 2024; 18:1436365.

PMID: 39483193 PMC: 11526447. DOI: 10.3389/fnhum.2024.1436365.